doi: 10.1111/j.1365-2125.1978.tb00877.x.
The features of hepatic enzyme induction with glutethimide in man
- PMID: 728322
- PMCID: PMC1429696
- DOI: 10.1111/j.1365-2125.1978.tb00877.x
Item in Clipboard
The features of hepatic enzyme induction with glutethimide in man
Br J Clin Pharmacol.
1978 Dec.
Abstract
1 Sequential measurements of D-glucaric acid excretion were made in six healthy volunteers before, during and after 3 weeks' daily medication with glutethimide 500 mg. 2 There was a rapid rise in D-glucaric acid excretion within 2 days of starting medication and a rapid decline when it was stopped. 3 Antipyrine clearance and indocyanine green clearance were measured before and at the end of the 3 weeks' medication. 4 There was a 55% increase in antipyrine clearance but no change in indocyanine green clearance. 5 There was no correlation between antipyrine clearance and D-glucaric acid excretion. 6 Glutethimide causes rapid enzyme induction in man without concomitant rise in hepatic blood flow.
Similar articles
-
Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.Biochem Pharmacol. 1974 Sep 1;23(17):2480-3. doi: 10.1016/0006-2952(74)90247-0. Biochem Pharmacol. 1974. PMID: 4429583 No abstract available.
-
Enzyme induction and serum and lipoprotein lipids: a study of glutethimide in normal subjects.Clin Sci (Lond). 1980 May;58(5):419-21. doi: 10.1042/cs0580419. Clin Sci (Lond). 1980. PMID: 7389270
-
Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.Int J Clin Pharmacol Res. 1986;6(3):235-9. Int J Clin Pharmacol Res. 1986. PMID: 3744626
-
Enzyme induction: its relevance for internal exposure and health risks.Int Arch Occup Environ Health. 1988;Suppl:76-83. doi: 10.1007/978-3-642-73476-2_9. Int Arch Occup Environ Health. 1988. PMID: 3049388 Review. No abstract available.
-
[Modification of the action of drugs by inhibition of their metabolism].Recenti Prog Med. 1979 Sep;67(3):313-45. Recenti Prog Med. 1979. PMID: 42953 Review. Italian. No abstract available.
Cited by
-
Clinical implications of enzyme induction and enzyme inhibition.Clin Pharmacokinet. 1981 Jan-Feb;6(1):1-24. doi: 10.2165/00003088-198106010-00001. Clin Pharmacokinet. 1981. PMID: 6113907 Review.
-
Physiological and pharmacological variability in estimated hepatic blood flow in man.Br J Clin Pharmacol. 1981 May;11(5):491-6. doi: 10.1111/j.1365-2125.1981.tb01155.x. Br J Clin Pharmacol. 1981. PMID: 6115663 Free PMC article.
-
Aminoglutethimide and warfarin. A new important drug interaction.Cancer Chemother Pharmacol. 1984;12(1):10-2. doi: 10.1007/BF00255901. Cancer Chemother Pharmacol. 1984. PMID: 6690067
-
D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.Br J Clin Pharmacol. 1986 Jan;21(1):9-18. doi: 10.1111/j.1365-2125.1986.tb02817.x. Br J Clin Pharmacol. 1986. PMID: 2868749 Free PMC article.
-
Assessment of the drug metabolism capacity of the liver.Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x. Br J Clin Pharmacol. 1982. PMID: 6128018 Free PMC article. Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
